ASTRO
Choosing Wisely After Publication of Level I Evidence in Breast Cancer Radiotherapy
March 30, 2018[Breast Cancer: Targets and Therapy] In this retrospective analysis of medical records and estimated costs of treatment, investigators demonstrated that rapid change based on level I evidence is feasible.
De-escalated Radiation Therapy Improves Quality of Life in Throat Cancer
September 29, 2017Aggressive de-escalation of chemoradiation after surgery in patients with HPV-associated OPSCC led to similar disease control and improved quality of life and safety profile compared with historical controls, according to data presented at the ASTRO 59th Annual Meeting.
Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
April 05, 2017Palliative radiotherapy for bone metastases is safe, effective — but controversy persists for single-fraction treatment.
ASTRO guidelines for endometrial cancer endorsed by ASCO
July 07, 2015Qualifications to guidelines include stronger statements in favor of chemotherapy in some cases.
ASTRO: Prostate cancer recovery faster with less androgen deprivation therapy
September 19, 2014Shorter time to testosterone recovery with 18 versus 36 months androgen deprivation therapy.
Guideline issued for postoperative radiation therapy for endometrial cancer
May 08, 2014The use of adjuvant radiation therapy in the treatment of endometrial cancer is detailed in a new guideline issued by the American Society of Radiation Oncology (ASTRO).
Optimizing quality and safety of high dose-rate brachytherapy
March 24, 2014Specific guidance for delivering high dose-rate brachytherapy to improve quality and safety is offered in a new white paper from the American Society for Radiation Oncology (ASTRO).
ASTRO: Simple screening IDs depression in Cancer Patients
September 25, 2013Two-item Patient Health Questionnaire can detect major depression in patients receiving radiotherapy.
Drug may reduce cognitive decline following radiation for brain metastases
November 22, 2012Memantine, which is already approved to help improve cognition in some patients with dementia, may limit declines in memory and cognitive function in patients who are undergoing WBRT to treat cancer that has spread to the brain.
Proton therapy preserves quality of life for men with prostate cancer
November 09, 2012Proton therapy preserves quality of life, meaning specifically urinary and bowel function, in men treated with this targeted radiation modality for prostate cancer. This research obtained information directly from the men who underwent the therapy, rather than from their treatment providers.
Reporting errors improves perceptions of safety and may reduce incidents
November 06, 2012This year-long study focused on the workflow of a Radiation Oncology department and found a strong correlation between implementing a Conditions Reporting System and increasingly positive responses to staff surveys that focused on the culture of safety within the department.
Higher risk of uterine cancer recurrence when radiation therapy after hysterectomy is delayed
November 05, 2012The risk of uterine cancer recurrence may be increased by waiting too long after a hysterectomy to begin radiation therapy. For patients with uterine cancer who are not receiving chemotherapy, tumors were found to be more likely to return if radiation therapy was delayed 9 weeks or longer following surgery.
Deviations from radiation protocols increase the risk of treatment failure and death
November 05, 2012When measures are implemented to ensure that radiation protocols are followed, deviations decrease and overall survival improves in patients with cancer.
Sign Up for Free e-newsletters
ONA Articles
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- Rituximab Maintenance Improved Long-Term Survival in Elderly With Follicular Lymphoma
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
- Antioxidant Interaction With Cancer Therapy
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- Myeloablative Conditioning Effective in AML Secondary to MDS/MPN Prior to Allogeneic HCT
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- American Association for Cancer Research Releases Its 2018 Annual Report
- Acrylamide in Food and Cancer Risk (Fact Sheet)
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- Use of Anti-inflammatory Analgesics Has a Positive Effect on Survival Outcomes in Ovarian Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |